Loss of bone mineral density after antiretroviral therapy initiation, independent of antiretroviral regimen. [electronic resource]
Producer: 20090814Description: 554-61 p. digitalISSN:- 1525-4135
- Absorptiometry, Photon
- Adult
- Alkynes
- Anti-HIV Agents -- adverse effects
- Benzoxazines -- adverse effects
- Bone Density -- drug effects
- Cyclopropanes
- Female
- HIV Infections -- complications
- Humans
- Inflammation Mediators -- blood
- Lamivudine -- adverse effects
- Lopinavir
- Male
- Middle Aged
- Osteoporosis -- chemically induced
- Prospective Studies
- Pyrimidinones -- adverse effects
- Receptors, Tumor Necrosis Factor, Type I -- blood
- Receptors, Tumor Necrosis Factor, Type II -- blood
- Risk Factors
- Ritonavir -- adverse effects
- Zidovudine -- adverse effects
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.